Does IPRAGLIFLOZIN L-PROLINE Cause Off label use? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Off label use have been filed in association with IPRAGLIFLOZIN L-PROLINE. This represents 4.0% of all adverse event reports for IPRAGLIFLOZIN L-PROLINE.
5
Reports of Off label use with IPRAGLIFLOZIN L-PROLINE
4.0%
of all IPRAGLIFLOZIN L-PROLINE reports
0
Deaths
4
Hospitalizations
How Dangerous Is Off label use From IPRAGLIFLOZIN L-PROLINE?
Of the 5 reports, 4 (80.0%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IPRAGLIFLOZIN L-PROLINE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does IPRAGLIFLOZIN L-PROLINE Cause?
Dehydration (11)
Diabetic ketoacidosis (11)
Cerebral infarction (10)
Hypoglycaemia (8)
Diabetes mellitus inadequate control (6)
Urinary tract infection (6)
Acute kidney injury (5)
Drug ineffective (5)
Lactic acidosis (5)
Myocardial infarction (5)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which IPRAGLIFLOZIN L-PROLINE Alternatives Have Lower Off label use Risk?
IPRAGLIFLOZIN L-PROLINE vs IPRATROPIUM
IPRAGLIFLOZIN L-PROLINE vs IPRATROPIUM\IPRATROPIUM ANHYDROUS
IPRAGLIFLOZIN L-PROLINE vs IPTACOPAN
IPRAGLIFLOZIN L-PROLINE vs IRBESARTAN
IPRAGLIFLOZIN L-PROLINE vs IRINOTECAN